ClinicalTrials.Veeva

Menu

Electro-acupuncture (EA) in Children Undergoing Procedures for Congenital Heart Defects.

West Virginia University logo

West Virginia University

Status

Completed

Conditions

Congenital Heart Defect

Treatments

Device: sham
Device: electro-acupuncture (EA)

Study type

Interventional

Funder types

Other

Identifiers

NCT03297658
1610318932

Details and patient eligibility

About

This is a single site, randomized, blinded, sham controlled, parallel group study to identify whether electro-acupuncture (EA) is a beneficial anesthesia adjunct in children undergoing procedures on their congenital heart defects (CHD).

Full description

This investigation is a single site, randomized, blinded, sham controlled, parallel group study to identify whether EA is a beneficial anesthesia adjunct in children undergoing procedures on their congenital heart defects.

Study subjects age's birth to eighteen years, undergoing cardiac surgery for their congenital heart lesions will be considered for entrance into the study. The randomized subjects will receive either EA or sham during their surgery for CHD. Subjects are expected to remain in the hospital 48 hours post procedure. Standard of care blood samples will be obtained pre-operative and post-operative. The only study specific blood sample will be Troponin I levels which will be obtained before surgery begins after the IV lines have been placed, and 6 hours after bypass. Urine samples will be obtained before surgery after placement of the foley catheter and every 6 hours post bypass aortic cross clamp removal for 48 hours while the foley catheter is still in place.

Enrollment

59 patients

Sex

All

Ages

Under 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients 0-18 years of age undergoing procedures on their congenital heart defects where an aortic cross clamp will be placed.

Additionally, patients with coarctation of the aorta for repair will be considered as a separate group and eligible for enrollment.

  • Willing to provide written Assent/Consent in English.

Exclusion criteria

  • Patients with skin lesions over more than 50% of EA sites.
  • Patients in renal failure.
  • Patients on chronic opioid therapy.
  • Unwilling to provide written Assent/Consent in English.

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

59 participants in 2 patient groups

electro-acupuncture (EA) intervention
Active Comparator group
Description:
Micro electrodes will be placed at PC 4 and 6 , LI 4 and ST36. subjects will receive electro-acupuncture (EA) (treatment) mixed frequency( continuous plus dense disperse) will be at 2Hz and 100 Hz the amplitude will be 1000 microA.
Treatment:
Device: electro-acupuncture (EA)
sham electro acupuncture
Sham Comparator group
Description:
Micro electrodes will be placed at PC 4 and 6 , LI 4 and ST36. subjects Receive sham (control) will not have stimulation.
Treatment:
Device: sham

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

David Rosen, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems